Kinesin motor proteins as targets for cancer therapy

Dennis Huszar1, Maria-Elena Theoclitou, Jeffrey Skolnik

  • 1Cancer Bioscience, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA.

Cancer Metastasis Reviews
|January 22, 2009
PubMed

Insights

Novel anti-mitotic drugs targeting mitotic kinesins offer a promising alternative to current therapies. These new agents aim for greater cancer cell selectivity and reduced side effects compared to existing treatments.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Mitosis is a validated target for cancer therapy, with current drugs acting on spindle microtubules.
  • Approved anti-mitotic drugs can cause significant side effects, including neurotoxicity.
  • Microtubule-targeting agents may lead to drug resistance.

Purpose of the Study:

  • To explore novel therapeutic strategies by targeting mitotic kinesins.
  • To develop more selective anti-mitotic drugs with improved side effect profiles.
  • To identify potential treatments that overcome resistance to existing therapies.

Main Methods:

  • Focus on drug discovery efforts targeting mitotic kinesins.
  • Investigate the spindle protein kinesin (KSP) as a primary target.
  • Clinical testing of novel kinesin inhibitors.

Main Results:

  • Mitotic kinesins represent a promising class of novel anti-mitotic drug targets.
  • Kinesin inhibitors offer potential for improved selectivity and reduced toxicity.
  • Compounds targeting KSP are advancing through clinical trials.

Conclusions:

  • Targeting mitotic kinesins provides a new avenue for cancer therapy development.
  • Kinesin inhibitors may offer a more effective and safer alternative to microtubule agents.
  • Further research and clinical evaluation of kinesin inhibitors are warranted.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
The Movement of Organelles and Vesicles01:43

The Movement of Organelles and Vesicles

In eukaryotic cells,  cytoskeletal filaments such as actin, microtubules, and intermediate filaments form a mesh-like cytoskeletal network. These filaments serve as tracks for transporting cellular cargo. Specialized motor proteins use the chemical energy stored in adenosine triphosphate (ATP) for this transport. During interphase, microtubules are polarized, with the plus-end towards the cell periphery and the minus-end towards the cell center. Two microtubule-associated motor proteins,...
Microtubule Associated Motor Proteins01:32

Microtubule Associated Motor Proteins

Eukaryotic cells have different motor proteins for transporting various cargo within the cell. These motor proteins differ based on the filament they associate with, the direction they move within the cell, and the type of cargo they transport. Motor proteins that associate with microtubules are known as microtubule-associated motor proteins. There are two families of microtubule-associated motor proteins —Kinesins and Dyneins. Both these proteins assist in the transport of cellular cargos...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...